当前位置:首页 - 行情中心 - 峆一药业(920478) - 财务分析 - 现金流量表

峆一药业

(920478)

  

流通市值:10.02亿  总市值:16.75亿
流通股本:4707.95万   总股本:7870.87万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金246,352,888.42185,289,389.890,095,716.87247,668,018.53
  收到的税费返还15,414,548.4610,829,843.036,739,803.8314,444,992.87
  收到其他与经营活动有关的现金4,703,819.582,281,261.452,150,688.513,833,212.68
  经营活动现金流入小计266,471,256.46198,400,494.2898,986,209.21265,946,224.08
  购买商品、接受劳务支付的现金123,954,978.3687,875,030.4147,527,984.85129,799,440.64
  支付给职工以及为职工支付的现金41,781,200.0327,933,538.9914,106,603.0948,277,684.03
  支付的各项税费15,267,208.2210,852,305.735,285,317.9922,724,192.94
  支付其他与经营活动有关的现金18,820,756.7111,693,599.297,014,528.223,682,896.04
  经营活动现金流出小计199,824,143.32138,354,474.4273,934,434.13224,484,213.65
  经营活动产生的现金流量净额66,647,113.1460,046,019.8625,051,775.0841,462,010.43
二、投资活动产生的现金流量:
  收回投资收到的现金370,000,000252,000,000137,000,000586,000,000
  取得投资收益收到的现金2,591,621.141,796,012.441,426,611.022,804,722.18
  处置固定资产、无形资产和其他长期资产收回的现金净额9508908905,000
  收到的其他与投资活动有关的现金340,883.9781,585.3247,428.41-
  投资活动现金流入小计372,933,455.11253,878,487.76138,474,929.43588,809,722.18
  购建固定资产、无形资产和其他长期资产支付的现金111,412,987.4677,697,769.6520,075,703.3944,801,604.82
  投资支付的现金315,330,000213,330,000123,000,000567,000,000
  投资活动现金流出小计426,742,987.46291,027,769.65143,075,703.39611,801,604.82
  投资活动产生的现金流量净额-53,809,532.35-37,149,281.89-4,600,773.96-22,991,882.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金---4,685,590
  取得借款收到的现金29,774,114.8916,202,514.89--
  收到其他与筹资活动有关的现金---4,832,075.02
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计29,774,114.8916,202,514.89-9,517,665.02
  分配股利、利润或偿付利息支付的现金22,488,20022,488,200-11,063,000
  支付其他与筹资活动有关的现金6,296,766.486,673,837.93458,277.977,801,561.99
  筹资活动现金流出小计28,784,966.4829,162,037.93458,277.9718,864,561.99
  筹资活动产生的现金流量净额989,148.41-12,959,523.04-458,277.97-9,346,896.97
四、汇率变动对现金及现金等价物的影响1,146,003.42909,071.61434,846.52,273,938.47
五、现金及现金等价物净增加额14,972,732.6210,846,286.5420,427,569.6511,397,169.29
  加:期初现金及现金等价物余额69,703,538.6969,703,538.6969,703,538.6958,306,369.4
  期末现金及现金等价物余额84,676,271.3180,549,825.2390,131,108.3469,703,538.69
补充资料:
  净利润-38,455,298.38-44,633,212.97
  资产减值准备--161,456.34-2,963,536.99
  固定资产和投资性房地产折旧-10,342,251.74-20,582,929.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,342,251.74-20,582,929.93
  无形资产摊销-387,820.16-683,558.32
  长期待摊费用摊销-354,351.62-416,156.98
  固定资产报废损失-11,502.28-119,991.58
  公允价值变动损失-606,856--460,620.39
  财务费用--927,414.19--2,137,010.6
  投资损失--1,796,012.44--3,324,305.74
  递延所得税--301,721.26--69,612.11
  其中:递延所得税资产减少--312,222.93--5,514.91
    递延所得税负债增加-10,501.67--64,097.2
  存货的减少--792,402.46-310,509.59
  经营性应收项目的减少-6,592,091.63--24,674,855.44
  经营性应付项目的增加-4,995,365.76--469,215.21
  其他-2,040,720.33-765,270.13
  现金的期末余额-80,549,825.23-69,703,538.69
  减:现金的期初余额-69,703,538.69-58,306,369.4
  现金及现金等价物的净增加额-10,846,286.54-11,397,169.29
公告日期2025-10-282025-08-192025-04-282025-04-18
审计意见(境内)标准无保留意见
TOP↑